โ† All Topics / ade

FDA ADE reports for Haemophilus Somnus Bacterin Toxoid

ade_haemophilus_somnus_bacterin_toxoid_adverse_events

ade en 2026-07-22

Haemophilus Somnus Bacterin Toxoid โ€” FDA Animal & Veterinary Adverse Event (ADE) Reports

Source: openFDA animalandveterinary/event.json, the FDA Center for Veterinary Medicine (CVM) adverse event report database. Data pulled 2026-07-22. Counts are report-level: one report may list multiple reactions and multiple animals, so figures are not additive and do not imply causation. Haemophilus Somnus Bacterin Toxoid is a active ingredient.

Total reports

Haemophilus Somnus Bacterin Toxoid: 17

Reports by species (top entries)

  • Cattle 17

Top reported reactions (VEDDRA terms, top entries)

  • Death 14
  • Lack of efficacy - NOS 8
  • Lack of efficacy (bacteria) - NOS 4
  • Necropsy performed 3
  • Lethargy (see also Central nervous system depression in 'Neurological') 2
  • Anaphylaxis 1
  • Death by euthanasia 1
  • Depression 1
  • Facial swelling (see also 'Skin') 1
  • Foam in the nose 1

Source JSON: pdf-raw/ade/ade_active_ingredients_2026-07-22_b27.json (openFDA animalandveterinary/event.json, pulled 2026-07-22).